跳至主要内容
临床试验/NCT02000232
NCT02000232已完成不适用

Impact of Unapproved Drug Initiative on Colchicine Use

Stanford University1 个研究点 分布在 1 个国家目标入组 185 人开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
185
试验地点
1
主要终点
Frequency of use of colchicine in an unapproved fashion in contemporary medical proactice.

研究概览

简要总结

Measure if FDA regulation of Colchicne in 2009 has resulted in safer use in clinical settings.

Our study will assess the impact of this Initiative on colchicine use and will provide data that supports its continuation and expansion.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of gout
  • Current use of colchicine/colcrys to treat gout
  • Ablility to provide Informed consent

排除标准

  • Inability to provide Informed consent

结局指标

主要结局

Frequency of use of colchicine in an unapproved fashion in contemporary medical proactice.

时间窗: This is an oberservational study and patients will be followed for upto 2 years from enrollment.

We expect to understand the impact of regulatory approach to colchicine preparation and how marketing can affect clinical use patterns in the real world.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验